SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Zeev's Turnips - No Politics

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rich Wolf who wrote (30748)2/18/2002 12:28:58 PM
From: Jdaasoc  Read Replies (1) of 99280
 
The initial 'investment' was an outright puchase of IMCL stock by BMY through a tender offer

I didn't know all the shares came from tender offer. I thought that besides the insiders 2 M share that remainder came from company's treasury shares.
That changes the picture greatly since they definitely will run out of money before Erbitux comes to market. They are still on a fast track pace to build, at BMY's potential expense, a $250 M production plant in NJ. Construction was still going gangbusters the last time I checked 2 weeks ago.

Anyone know details on Merck KaGA clinical trial status.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext